The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: Implications for adjuvant therapeutic strategies
Open accessAbstract
BACKGROUND: Current approaches to adjuvant treatment after resection of gallbladder carcinoma (GBCA) and hilar cholangiocarcinoma (HCCA) are based on an incomplete understanding of the recurrence patterns of these diseases. Through an in‐depth analysis of the sites of initial recurrence after resection of GBCA and HCCA, the current study aimed to highlight differences in the biology of these tumors and to provide further insight for adjuvant therapeutic strategies. METHODS: Patients with either GBCA or HCCA who underwent a potentially curative resection were identified prospectively from a maintained database. Specific sites of initial disease recurrence were identified retrospectively and categorized as locoregional (resection margin, porta hepatis, or retroperitoneal lymph nodes) or distant (peritoneal, extraabdominal, or discontiguous liver metastases). Differences in disease recurrence patterns, time to disease recurrence, and overall and site‐specific survival were analyzed. RESULTS: Between May 1990 and August 2001, 177 patients underwent potentially curative resection, 97 for GBCA and 80 for HCCA. Disease recurrence and follow‐up data were available for 156 patients (80 with GBCA and 76 with HCCA). The median time to disease recurrence was shorter for patients with GBCA compared with patients with HCCA (11.5 vs. 20.3 months; P = 0.007). Overall, 52 (68%) patients with HCCA and 53 (66%) patients with GBCA had disease recurrene at a median follow‐up of 24 months. Of those who developed disease recurrence, isolated locoregional disease as the first site of failure occurred in 15% of patients with GBCA compared with 59% of patients with HCCA (P < 0.001). By contrast, an initial GBCA recurrence involving a distant site, with or without concomitant locoregional recurrence, occurred in 85% of patients compared with 41% of patients with HCCA (P < 0.001). This pattern of disease recurrence was diagnosis specific and did not change significantly when patients were stratified by several clinicopathologic factors, including disease stage and its component variables. Using multivariate analysis, diagnosis was an independent predictor of the site of disease recurrence. Among patients who experienced disease recurrence, survival was greater among the patients with HCCA compared with patients with GBCA (29 months vs. 20.6 months, respectively; P = 0.037). For both tumors, the site of initial disease recurrence had no apparent impact on survival time. CONCLUSIONS: After resection, recurrent GBCA is much more likely than recurrent HCCA to involve a distant site. GBCA is also associated with a much shorter time to recurrence and a shorter survival period after recurrence. The results demonstrated significant differences in the clinical behavior of these tumors and suggested that an adjuvant therapeutic strategy targeting locoregional disease, such as radiotherapy, is unlikely to have a significant impact in the overall management of GBCA. Conversely, there is at least some rationale for such an approach in patients with HCCA based on the pattern of initial recurrence. Cancer 2003. © 2003 American Cancer Society. DOI 10.1002/cncr.11699
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
American Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. (2001) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.1.15 · Cited by 3,288
Spiess, P. E., Lee, A. K., Leibovici, D., Wang, X., Do, K., & Pisters, L. L. (2006) · Cancer · doi:10.1002/cncr.21979 · Cited by 1,930
Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma
Jarnagin, W. R., Fong, Y., DeMatteo, R. P., Gonen, M., Burke, E. C., Bodniewicz, J., Youssef, M., Klimstra, D., & Blumgart, L. H. (2001) · Annals of Surgery · doi:10.1097/00000658-200110000-00010 · Cited by 1,347
Self-citationManagement Strategies in Resection for Hilar Cholangiocarcinoma
BISMUTH, H., NAKACHE, R., & DIAMOND, T. (1992) · Annals of Surgery · doi:10.1097/00000658-199201000-00005 · Cited by 807
Long-Term Results after Resection for Gallbladder Cancer: Implications for Staging and Management
Bartlett, D. L., Fong, Y., Fortner, J. G., Brennan, M. F., & Blumgart, L. H. (1996) · Annals of Surgery · doi:10.1097/00000658-199611000-00008 · Cited by 393
Self-citationTumor Seeding following Laparoscopy: International Survey
Paolucci, V., Schaeff, B., Schneider, M., & Gutt, C. (1999) · World Journal of Surgery · doi:10.1007/s002689900613 · Cited by 312
Perihilar Cholangiocarcinoma Postoperative Radiotherapy Does Not Improve Survival
Pitt, H. A., Nakeeb, A., Abrams, R. A., Coleman, J., Piantadosi, S., Yeo, C. J., Lillemoe, K. D., & Cameron, J. L. (1995) · Annals of Surgery · doi:10.1097/00000658-199506000-00017 · Cited by 299
Todoroki, T., Ohara, K., Kawamoto, T., Koike, N., Yoshida, S., Kashiwagi, H., Otsuka, M., & Fukao, K. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00472-1 · Cited by 194
Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile.
Wistuba, I. I., Sugio, K., Hung, J. Y., Kishimoto, Y., Virmani, A. K., Roa, I., Albores‐Saavedra, J., & Gazdar, A. F. (1995) · PubMed · Cited by 155
Wullstein, C., Woeste, G., Barkhausen, S., Gross, E., & Hopt, U. T. (2002) · Surgical Endoscopy · doi:10.1007/s00464-001-9085-7 · Cited by 93
Cellular and molecular biology of biliary tract cancers
Rashid, A. (2002) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(02)00042-x · Cited by 85
Tumor Cell Dissemination during Laparoscopy: Prevention and Therapeutic Opportunities
Steinert, R., Lippert, H., & Reymond, M. A. (2002) · Digestive Surgery · doi:10.1159/000067598 · Cited by 36
Surgery for hilar cholangiocarcinoma -- the German experience
Neuhaus, P., & Jonas, S. (2000) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340050168 · Cited by 32
Nagai, M., Kawarada, Y., Watanabe, M., Iwase, T., Muneyuki, T., Yamao, K., Fukutome, K., & Yatani, R. (1999) · PubMed · Cited by 25
Cited by
Benson, A. B., Abrams, T. A., Ben-Josef, E., Bloomston, P. M., Botha, J. F., Clary, B. M., Covey, A., Curley, S. A., D'Angelica, M. I., Davila, R., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0027 · Cited by 2,268
Self-citationAdjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
Horgan, A. M., Amir, E., Walter, T., & Knox, J. J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.5381 · Cited by 716
Rea, D. J., Heimbach, J. K., Rosen, C. B., Haddock, M. G., Alberts, S. R., Kremers, W. K., Gores, G. J., & Nagorney, D. M. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000179678.13285.fa · Cited by 693
Darwish Murad, S., Kim, W. R., Harnois, D. M., Douglas, D. D., Burton, J., Kulik, L. M., Botha, J. F., Mezrich, J. D., Chapman, W. C., Schwartz, J. J., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.008 · Cited by 597
Gallbladder cancer (GBC): 10‐year experience at Memorial Sloan‐Kettering Cancer Centre (MSKCC)
Duffy, A., Capanu, M., Abou‐Alfa, G. K., Huitzil, D., Jarnagin, W., Fong, Y., D'Angelica, M., DeMatteo, R. P., Blumgart, L. H., & O'Reilly, E. M. (2008) · Journal of Surgical Oncology · doi:10.1002/jso.21141 · Cited by 473
Self-citation
Metadata
- Authors
- Jarnagin, W. R., Ruo, L., Little, S. A., Klimstra, D., D'Angelica, M., DeMatteo, R. P., Wagman, R., Blumgart, L. H., & Fong, Y.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2003-08-21
- Volume
- 98
- Issue
- 8
- Pages
- 1689-1700
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2059922433
- Cited by
- 454
- References
- 18
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.